Skip Ribbon Commands
Skip to main content

Oncology Regional Care Advancement (ORCA) Symposium

Saturday, March 16, 2013 

Please join us for our inaugural Oncology Regional Care Advancement (ORCA) Symposium. The goal of this conference is to provide in-depth guidance to providers to help patients navigate the often confusing world of cancer diagnosis and treatment. For certain cancers, early detection tips, advances in medical management, radiation and surgical treatment options and issues related to post cancer treatments will be reviewed. Cancer can be a devastating diagnosis, and by working together in the community, we can ensure the best patient-centered approach.

Date

Saturday, March 16, 2013 

Who Should Attend

Primary Care Providers, including Family Practitioners and Internists, Emergency Medicine Physicians, Physician Assistants, Nurse Practitioners, Nurses, and other health care professionals who treat patients with cardiovascular disease.

Location

Windows on the Bay is located at 2625 S. Harbor Loop Drive, Bellingham, Washington. (Located inside the Bellingham Yacht Club Building in Squalicum Harbor)

Registration Fees

Registration fee until February 1, 2013 - $50

Registration fee after February 1, 2013- $75

Registration

To register please call Lisa Brown, (360) 788-6808 or (800) 541-7209 ext. 6808

Conference Agenda

 

Time
Speaker/Activity
7:30-8:00 a.m.
Registration
Breakfast
8:00-8:05 a.m.
Welcome
 
8:05-9:00 a.m.
Looking for Laughter in All the Wrong Places
Scott Burton
9:00-10:00 a.m.
 
Session 1: HPV & Head and Neck Cancers
Moderator: Jennie Crews, MD, FACP
9:00-9:45 a.m.
 

 Head and Neck Cancer in the Era of HPV

William Hall, MD 

HPV.pdfHPV.pdf

9:45-9:55 a.m.
 
Helping Patients Navigate Their Care
Kim Moses, RN
 
9:55-10:05 a.m.
Session 1 Q&A – All Session 1 Presenters
Facilitator: Marcy Hipskind, MD
10:05-10:15 a.m.
Break
 
10:15-11:15 a.m.
 
Session 2: Lung Cancer
Moderator: Jennie Crews, MD, FACP
10:15-10:25 a.m.
 
Current Screening Recommendations
Jennie Crews, MD,FACP
10:25-10:50 a.m.
 
Management of Early Stage Lung Cancer
Richard J. Leone, MD, PhD, FACS
10:50-11:15 a.m.
 
Management of Late Stage Lung Cancer
Andrew Kominsky, MD
11:15-11:25 a.m.
Helping Patients Navigate Their Care
Kathy Millson, RN
11:25-11:35 a.m.
 
Session 2 Q&A - All Session 2 Presenters
Facilitator: Marcy Hipskind, MD
11:35-11:45 a.m.​
Break
 
11:45 a.m.-1:00 p.m.
 
 
Session 3: Breast Cancer
Moderator: Jennie Crews, MD, FACP
11:45 a.m.-12:45 p.m.
Changing Perspectives of Breast Cancer Treatment
William Hall, MD
Cary Kaufman, MD
12:45- 1:00 p.m.
 
 Session 3 Q&A – All Session 3 Presenters
Facilitator: Marcy Hipskind, MD
 
1:00-1:30 p.m.
LUNCH
1:30-2:15 p.m.
Session 4: Hereditary Cancers
Moderator: Jennie Crews, MD, FACP
1:30-2:05 p.m.
Screening Your Patients for Hereditary Cancers and A Guide to Talking with Your Patients
Heidi Kay Holmes, Licensed Genetic Counselor
2:05-2:15 p.m.
 
Session 4Q&A
Facilitator: Marcy Hipskind, MD
2:15-2:25 p.m.
Final Questions and Wrap UP
Moderator: Jennie Crews, MD & Marcy Hipskind, MD
2:25-2:30 p.m.
Time to complete Evaluations

 ​

Accreditation​

PeaceHealth St. Joseph Medical Center is accredited by the Washington State Medical Association CME Accreditation Committee to sponsor continuing medical education activities for physicians.

 

PeaceHealth St. Joseph Medical Center designates this activity for a maximum of 5 hours in Category I to satisfy the re-licensure requirements of the Washington State Medical Quality Assurance Commission.

 

PeaceHealth St. Joseph Medical Center designates this live activity for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Event Committee

 Jennie Crews, MD, FACP - Event Chair

William Hall, MD - Event Co-Chair

Marcy Hipskind, MD - Event Committee

Richard J. Leone, MD, PhD, FACS, FCCP - Event Committee

Lisa Brown, Event Coordinator

Sponsors

Platinum

Genomic Health

Exhibitors

Alexion, Astra Zeneca, Carsis, Celgene, Millennium: the Takeda Oncology Company ​
​​​​​​